Cargando…
Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025751/ https://www.ncbi.nlm.nih.gov/pubmed/33800101 http://dx.doi.org/10.3390/curroncol28020110 |
_version_ | 1783675549426647040 |
---|---|
author | Liontos, Michalis Papatheodoridi, Alkistis Andrikopoulou, Angeliki Thomakos, Nikolaos Haidopoulos, Dimitrios Rodolakis, Alexandros Zagouri, Flora Bamias, Aristotelis Dimopoulos, Meletios-Athanasios |
author_facet | Liontos, Michalis Papatheodoridi, Alkistis Andrikopoulou, Angeliki Thomakos, Nikolaos Haidopoulos, Dimitrios Rodolakis, Alexandros Zagouri, Flora Bamias, Aristotelis Dimopoulos, Meletios-Athanasios |
author_sort | Liontos, Michalis |
collection | PubMed |
description | Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older than 70 years of age. Methods: Medical records of women with high-grade serous ovarian cancer, stage III and IV were retrospectively analyzed. Results: A total of 735 patients were identified with a median age of 61.5 years. 22.4% among them were older than 70 years of age at diagnosis. First-line Progression-Free Survival (PFS) and Overall Survival (OS) were significantly worse in elderly patients in comparison to the younger ones [mPFS 11.3 months vs. 14.8 months, (p < 0.001) and mOS 30.2 months vs. 45.6 months (p < 0.001)]. However, elderly patients were characterized by worse ECOG-Performance Status and they were more frequently treated with Neoadjuvant Chemotherapy followed by Interval Debulking Surgery, while often they were more frequently denied debulking surgery compared to patients under 70 years of age. Moreover, elderly patients received more frequently monotherapy with platinum as frontline treatment. In contrast, there was no significant difference in the outcome of the debulking surgery in comparison to the younger patients or the frequency that gBRCA test was performed. Age over 70 years did not retain its significance for either Progression-Free Survival or Overall Survival when adjusted for all other reported prognostic factors. Conclusions: Elderly ovarian cancer patients have a worse prognosis. Comprehensive geriatric assessment should be performed for the optimal treatment of these patients. |
format | Online Article Text |
id | pubmed-8025751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80257512021-04-08 Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting Liontos, Michalis Papatheodoridi, Alkistis Andrikopoulou, Angeliki Thomakos, Nikolaos Haidopoulos, Dimitrios Rodolakis, Alexandros Zagouri, Flora Bamias, Aristotelis Dimopoulos, Meletios-Athanasios Curr Oncol Article Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older than 70 years of age. Methods: Medical records of women with high-grade serous ovarian cancer, stage III and IV were retrospectively analyzed. Results: A total of 735 patients were identified with a median age of 61.5 years. 22.4% among them were older than 70 years of age at diagnosis. First-line Progression-Free Survival (PFS) and Overall Survival (OS) were significantly worse in elderly patients in comparison to the younger ones [mPFS 11.3 months vs. 14.8 months, (p < 0.001) and mOS 30.2 months vs. 45.6 months (p < 0.001)]. However, elderly patients were characterized by worse ECOG-Performance Status and they were more frequently treated with Neoadjuvant Chemotherapy followed by Interval Debulking Surgery, while often they were more frequently denied debulking surgery compared to patients under 70 years of age. Moreover, elderly patients received more frequently monotherapy with platinum as frontline treatment. In contrast, there was no significant difference in the outcome of the debulking surgery in comparison to the younger patients or the frequency that gBRCA test was performed. Age over 70 years did not retain its significance for either Progression-Free Survival or Overall Survival when adjusted for all other reported prognostic factors. Conclusions: Elderly ovarian cancer patients have a worse prognosis. Comprehensive geriatric assessment should be performed for the optimal treatment of these patients. MDPI 2021-03-07 /pmc/articles/PMC8025751/ /pubmed/33800101 http://dx.doi.org/10.3390/curroncol28020110 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Liontos, Michalis Papatheodoridi, Alkistis Andrikopoulou, Angeliki Thomakos, Nikolaos Haidopoulos, Dimitrios Rodolakis, Alexandros Zagouri, Flora Bamias, Aristotelis Dimopoulos, Meletios-Athanasios Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title | Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title_full | Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title_fullStr | Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title_full_unstemmed | Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title_short | Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting |
title_sort | management of the elderly patients with high-grade serous ovarian cancer in the real-world setting |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025751/ https://www.ncbi.nlm.nih.gov/pubmed/33800101 http://dx.doi.org/10.3390/curroncol28020110 |
work_keys_str_mv | AT liontosmichalis managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT papatheodoridialkistis managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT andrikopoulouangeliki managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT thomakosnikolaos managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT haidopoulosdimitrios managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT rodolakisalexandros managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT zagouriflora managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT bamiasaristotelis managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting AT dimopoulosmeletiosathanasios managementoftheelderlypatientswithhighgradeserousovariancancerintherealworldsetting |